Granulomatous hepatitis associated with glyburide
- 36 Downloads
A wide variety of diseases and injuries can cause granulomatous hepatitis, and drug-induced granulomatous hepatitis is a well-described entity. Sulfonylurea derivatives, which are commonly used oral hypoglycemic agents in the treatment of non-insulin-dependent diabetes mellitus, have been implicated in liver disease. However, glyburide, a second-generation sulfonylurea and a potent hypoglycemic drug, is considered to have less hepatic side effects than chlorpropamide. It has been reportedly associated with cholestatic jaundice and hepatitis and with hypersensitivity angiitis. A case of necrotizing granuloma has been reported. We present a second case of granulomatous hepatitis occurring in a patient who had been taking glyburide for approximately three years, and we review the literature for glyburide-associated hepatitis.
Key wordsliver granuloma glyburide
Unable to display preview. Download preview PDF.
- 3.Ingelmo M, Vivancos J, Bruguera M, Sierra J, Balcells A: Angiitis por hipersensibilidad y hepatitis granulomatosa inducida por glibenclamida; a proposito de un caso. Med Clin (Barc) 74:306–308, 1980Google Scholar
- 4.James DG: Granulomatous liver disease.In Diseases of the Liver. L Schiff, ER Schiff (eds). Philadelphia JB Lippincott, 1993, pp 1499–1504Google Scholar
- 6.De Rosa G, Corsello SM, Pizzi C, Modesti A, Della-Casa S, Pasargiklian E: Epatopatic citolitica anitterica da glibenclamide. Epatologia 26(2):73–78, 1980Google Scholar
- 8.Meadow P, Tullio CJ: Glyburide-induced hepatitis. Clin Pharmacol 8:470, 1989Google Scholar
- 9.Lambert M, Geubel A, Rahier J, Branquinho F: Cholestatic hepatitis associated with glibenclamide therapy, a case report. Eur J Gastroenterol and Hepatol 2:389–391, 1990Google Scholar